Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures
This study has been completed.
Study NCT00154141   Information provided by Ethicon, Inc.

First Received on September 7, 2005.   Last Updated on July 11, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peripheral Vascular Disease
Additional conditions recognized in this trial
Peripheral Arterial Disease
Peripheral Vascular Diseases
Vascular Diseases
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Atherosclerosis
Cardiovascular Diseases
Interventions listed in this trial
Fibrin sealant (FS2)
Additional drug interventions recognized in this trial
Fibrin Tissue Adhesive
More general drug interventions related to this trial
Coagulants
Hematologic Agents
Hemostatics
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Ethicon, Inc.
OMRIX Biopharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services